MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SCNI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Scinai Immunotherapeutics (SCNI) Ownership - Who owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
45
Web
https://www.scinai.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.55M
P/E Ratio
0.17
Total Cash
989K
Projected Growth
N/A
Total Debt
2.36M
Revenue
1.15M
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.43 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SCNI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SCNI
A.I. Advisor
published General Information

General Information

a manufacturer of the innovative flu vaccine

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
45
Web
https://www.scinai.com